NUMAB AG has a total of 39 patent applications. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are LAVA THERAPEUTICS B V, QUADRUCEPT BIO LTD and BERNETT MATTHEW J.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Canada | 5 | |
#3 | China | 5 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | United States | 5 | |
#6 | Hong Kong | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Singapore | 3 | |
#9 | Australia | 2 | |
#10 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Analysing materials | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Urech David | 38 |
#2 | Meyer Sebastian | 37 |
#3 | Gunde Tea | 28 |
Publication | Filing date | Title |
---|---|---|
WO2016202457A1 | Hetero-dimeric multi-specific antibody format | |
WO2016184570A1 | Novel treatment methods based on multifunctional molecules | |
WO2015172800A1 | Novel multispecific molecules and novel treatment methods based on such multispecific molecules | |
CA2926153A1 | Bispecific constructs and their use in the treatment of various diseases | |
AU2014339295A1 | Bispecific constructs and their use in the treatment of various diseases | |
CN105579472A | Novel antibody frameworks | |
WO2014191113A1 | Novel antibodies | |
SG11201509259RA | Bispecific constructs and their use in the treatment of various diseases |